Abstract
Abstract
Introduction: Asthma is the most common and best understood chronic disease in childhood, but the diagnosis and management of this disorder is a challenge for pediatricians and for the entire health-care system. Management of asthma depends upon the severity of attack and may include nebulized β2-agonists, anticholinergic agents, inhaled and systemic steroids, Intravenous magnesium sulphate and oxygen supplementation. Use of inhaled magnesium sulphate had been emerging as aninteresting topic for research. Many studies have come up with the conclusion that nebulized MgSO4 in patients with asthma exacerbation results in earlier improvement in clinical signs and symptoms, significant improvement in lung function and consequently a faster recovery. We undertook this study to analyze possibility of any added benefit when nebulized Mgso4 is used in the initial treatment along with the standard drugs in children with acute attack of asthma /wheeze.
Aims and Objectives 1. To know the effectiveness of combined inhaled salbutamol and ipratropium in magnesium sulphate over salbutamol and ipratropium in isotonic saline in acute moderate asthma in children. 2. To compare the efficacy of combined inhaled salbutamol and ipratropium in magnesium sulphateover salbutamol and ipratropium in isotonic saline in acute moderate asthma in children.
Materials and Methods: This was an open-labelled randomized controlled trial consisting of children in the age group of 2 to 14years attending pediatric OPD with wheeze according to GINA guidelines and PRAM scores. 100 children included in this study were divided into 2 groups. Children in Group A received standard treatment of Salbutamol along with Ipratropium and Normal saline while children in group Breceived Salbutamol along with Ipratropium and MgSo4 nebulization as treatment. The effectiveness and comparison of efficacy of treatment in these groups were studied. Student ’t’ test and chi square tests were used to find the significance of study parameters. P value less than 0.05 was considered as significant.
Results: Out of the 100 children who were included in this study there were 60 (60%) males and 40 (40%) females with a M:F ratio of 1.5:1. Mean age and weights were found to be comparable in both the groups. There was a statistically significant family history in Group A. PRAM scores at 0,20,40 and 60 minutes were statistically significantly higher in patients of Group A than in Group B. Heart rates at 0,20,40 and 60 minutes were comparable in both the groups and there was no statistically significant difference in both the groups. Respiratory rates were statistically significantly higher in Group A at 20,40 and 60 minutes. SpO2 levels were higher at 20 and 40 minutes. Peak expiratory flow rates were found to be comparable in both the groups. The analysis of patients on the basis of need to revisit the hospital showed that there was no statistically significant difference in hospitalrevisit rates in both the groups. There were no cases of treatment failure in any of the groups.
Conclusion: Inhaled Magnesium along with the standard treatment gives a significantly better clinical improvement in acute moderate asthma. Hence Inhaled magnesium along with standard treatment given as nebulization may be considered as initial treatment for use in moderate to severe acute asthma in children.
Keywords: Acute moderate asthma, inhaled MgSO4, PRAM Scores, Peak Expiratory Flow Rates
References
- Global Initiative for Asthma. GINA Report: Global strategy for asthma management and prevention (online). 2013; available from : URL: http://www.ginasthma.com
- Mani SK. Clinical evaluation and assessment of severity. In: Diagnosis and management of asthma. 4th United states of America: professional communications,Inc; 2007. p38-39
- Sheehan WJ, Rangsithienchai PA, Wood RA, et al. Pest and allergen exposure and abatement in inner-city asthma: A Work Group Report of the American Academy of Allergy, Asthma & Immunology Indoor Allergy/Air Pollution Committee. The Journal of allergy and clinical immunology. 2010;125(3):575-581.
- Brigham EP, West NE. Diagnosis of asthma: diagnostic testing. Int Forum Allergy Rhinol. 2015 Sep;5 Suppl 1:S27-30.
- Chalut DS, Ducharme FM, Davis GM. The Preschool Respiratory Assessment Measure (PRAM): a responsive index of acute asthma severity. J Pediatr. 2000 Dec;137(6):762–768.
- Sarhan HA, EL-Garhy OH, Ali MA, Youssef NA. The efficacy of nebulized magnesium sulfate alone and in combination with salbutamol in acute asthma. Drug Design, Development and Therapy. 2016;10:1927-1933.
- Reddy AP, Gupta MR. Management of asthma: the current US and European guidelines. Adv Exp Med Biol. 2014;795:81-103. Review.
- Kokotajlo S, Degnan L, Meyers R, Siu A, Robinson C. Use of Intravenous Magnesium Sulfate for the Treatment of an Acute Asthma Exacerbation in Pediatric Patients. The Journal of Pediatric Pharmacology and Therapeutics : JPPT. 2014;19(2):91-97.
- Sydow M, Crozier TA, Zielmann S. High-dose intravenous magnesium sulfate in the management of life-threatening status asthmaticus. Intensive Care Med. 1993;19 (8):467–471.
- Nannini LJ Jr, Pendino JC, Corna RA, Mannarino S, Quispe R. Magnesium sulfate as a vehicle for nebulized salbutamol in acute asthma. Am J Med. 2000 Feb 15; 108(3):193–7.
- Bessmertny O, DiGregorio RV, Cohen H, Becker E, Looney D, Golden J et al. A randomized clinical trial of nebulized magnesium sulfate in addition to albuterol in the treatment of acute mild-to-moderate asthma exacerbations in adults. Ann Emerg Med. 2002 Jun; 39(6):585–91.
- Mangat HS, D’Souza GA, Jacob MS. Nebulized magnesium sulphate versus nebulized salbutamol in acute bronchial asthma: a clinical trial. Eur Respir J. 1998 Aug;12(2):341–4.
- Powell CV. The role of magnesium sulfate in acute asthma: does route of administration make a difference? :Curr Opin Pulm Med. 2014 Jan;20(1):103-8.
- Mahajan P, Haritos D, Rosenberg N, Thomas R. Comparison of nebulized magnesium sulfate plus albuterol to nebulized albuterol plus saline in children with acute exacerbations of mild to moderate asthma. J Emerg Med. 2004 Jul;27(1):21–5.
- Hughes RJ, Goldkorn AL, Masoli M, Weatherall M, Burgess C, Beasley CR. The use of isotonic nebulized magnesium as an adjuvant to salbutamol in the treatment of severe asthma in adults: Randomised placebo-controlled trial. Lancet 2003;361(9375):2114–7.
- Blitz M, Blitz S, Hughes R, Diner B, Beasley R, Knopp J, Rowe BH. Aerosolized magnesium sulfate for acute asthma: a systematic review. Chest. 2005 Jul;128(1):337-44. Review. Erratum in: Chest. 2005 Nov;128(5):3779.
- Albuali WH. The use of intravenous and inhaled magnesium sulphate in management of children with bronchial asthma. J Matern Fetal Neonatal Med. 2014 Nov;27(17):1809-15.
- Gandia F, Guénard H, Sriha B, Tabka Z, Rouatbi S. Inhaled magnesium sulphate in the treatment of bronchial hyperresponsiveness. Magnes Res. 2012 Dec;25(4):168-76.
- Knightly R, Milan SJ, Hughes R, Knopp-Sihota JA, Rowe BH, Normansell R, Powell C. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev. 2017 Nov 28;11:CD003898.
- Sun YX, Gong CH, Liu S, Yuan XP, Yin LJ, Yan L, Shi TT, Dai JH. Effect of inhaled MgSO4 on FEV1 and PEF in children with asthma induced by acetylcholine: a randomized controlled clinical trail of 330 cases. J Trop Pediatr. 2014 Apr;60(2):141-7.
Corresponding Author
Dr Kiran Raj H
Senior Resident, Department of Pediatrics,
Srinivas Institute of Medical Sciences and Research Centre, Mukka, Mangaluru, India
This email address is being protected from spambots. You need JavaScript enabled to view it.
DOI: https://dx.doi.org/10.18535/jmscr/v6i5.162
